{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T03:26:04Z","timestamp":1648783564284},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T00:00:00Z","timestamp":1624838400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s00120-021-01574-w","type":"journal-article","created":{"date-parts":[[2021,6,28]],"date-time":"2021-06-28T16:04:10Z","timestamp":1624896250000},"page":"886-894","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Konventionelles vs. molekulares Grading"],"prefix":"10.1007","volume":"60","author":[{"given":"C.","family":"Kakies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Louise Dr\u00e4ger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Spiess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. W.","family":"Hakenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Protzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,6,28]]},"reference":[{"key":"1574_CR1","unstructured":"Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF): S3-Leitlinie Diagnostik, Therapie und Nachsorge des Peniskarzinoms, Langversion 1.0, 2020, AWMF Registernummer: 043-042OL, https:\/\/www.leitlinienprogramm-onkologie.de\/leitlinien\/peniskarzinom\/, (abgerufen am 14. M\u00e4rz 2021)"},{"key":"1574_CR2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1212233","author":"M Roiner","year":"2018","unstructured":"Roiner\u00a0M, Maurer\u00a0O, Lebentrau\u00a0S et\u00a0al (2018) Management of penile cancer patients\u2014new aspects of a\u00a0rare tumor entity. Aktuelle Urol. https:\/\/doi.org\/10.1055\/s-0043-1212233","journal-title":"Aktuelle Urol"},{"key":"1574_CR3","unstructured":"TNM-System und Staging: Befunde verstehen und einordnen, Krebsinformationsdienst des Deutschen Krebsforschungszentrums (DKFZ), Heidelberg. 22. April 2010. Zuletzt abgerufen am 14. M\u00e4rz 2021"},{"key":"1574_CR4","unstructured":"UICC Origin of World Cancer Day Frequently Asked Questions. worldcancerday.org. Zugegriffen: 14. M\u00e4rz 2021"},{"issue":"1","key":"1574_CR5","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.eururo.2014.10.017","volume":"67","author":"O Hakenberg","year":"2014","unstructured":"Hakenberg\u00a0O, Comperat\u00a0EM, Minhas\u00a0S et\u00a0al (2014) EAU giudelines on penile cancer: 2014 update. Eur Urol 67(1):142\u2013150","journal-title":"Eur Urol"},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00120-018-0592-8","volume":"57","author":"A Erbersdobler","year":"2018","unstructured":"Erbersdobler A (2018) Pathologie und histopathologische Begutachtung des Peniskarzinoms. Urologe 57:391\u2013397","journal-title":"Urologe"},{"issue":"7","key":"1574_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1097\/PAS.0b013e3181641365","volume":"32","author":"EF Velazquez","year":"2008","unstructured":"Velazquez\u00a0EF et\u00a0al (2008) Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5 to 10\u202fmm. Am J Surg Pathol 32(7):974\u2013979","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"1574_CR8","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00428-014-1548-z","volume":"464","author":"C Kakies","year":"2014","unstructured":"Kakies\u00a0C et\u00a0al (2014) Reproducibility of histopathologic tumor grading in penile cancer\u2014results of a\u00a0European project. Virchows Arch 464(4):453\u2013461","journal-title":"Virchows Arch"},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s00120-018-0596-4","volume":"57","author":"M May","year":"2018","unstructured":"May M, Brookman-May SD, Ecke TH, Burger M (2018) Die molekulare Charakterisierung des Peniskarzinoms \u2013 Literaturreview zu neuen Prognosemarkern und potentiellen Therapietargets. Urologe 57:398\u2013407","journal-title":"Urologe"},{"issue":"11","key":"1574_CR10","first-page":"1197","volume":"22","author":"C Protzel","year":"2007","unstructured":"Protzel\u00a0C et\u00a0al (2007) Expression of proliferation marker Ki67 correlates to occurrence of metastasis and prognosis, histological subtypes and HPV DNA detection in penile carcinomas. Histol Histopathol 22(11):1197\u20131204","journal-title":"Histol Histopathol"},{"issue":"6","key":"1574_CR11","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jclinpath-2011-200638","volume":"65","author":"E Stankiewicz","year":"2012","unstructured":"Stankiewicz\u00a0E et al (2012) The prognostic value of Ki-67 expression in penile squamous cell carcinoma. J\u00a0Clin Pathol 65(6):534\u2013537","journal-title":"J Clin Pathol"},{"issue":"1","key":"1574_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-5347(05)65389-X","volume":"167","author":"AC Martins","year":"2002","unstructured":"Martins\u00a0AC, Faria\u00a0SM, Cologna\u00a0AJ, Suaid\u00a0HJ, Tucci\u00a0S (2002) Immunoexpressionof p53 protein and proliferating cell nuclear antigen in penile cancer. J\u00a0Urol 167(1):89\u201392","journal-title":"J Urol"},{"issue":"1","key":"1574_CR13","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.urology.2007.03.003","volume":"70","author":"GC Guimar\u00e4es","year":"2007","unstructured":"Guimar\u00e4es\u00a0GC, Leal\u00a0ML, Campos\u00a0RS et al (2007) Do proliferating cell nuclear antigen and MIB-1\/Ki 67 have prognostic value in penile squamous cell carcinoma? Urology 70(1):137\u2013142","journal-title":"Urology"},{"issue":"10","key":"1574_CR14","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1158\/1055-9965.EPI-18-0322","volume":"27","author":"FL Sand","year":"2018","unstructured":"Sand\u00a0FL et al (2018) Prognostic significance of HPV and p16 status in men diagnosed with penile cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 27(10):1123\u20131132","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1574_CR15","doi-asserted-by":"crossref","unstructured":"Zhang J et al (2018) Prognostic significance of P16(INK4a) expression in penile squamous cell carcinoma: a meta-analysis with trial sequential analysis. Biomed Res Int","DOI":"10.1155\/2018\/8345893"},{"issue":"1","key":"1574_CR16","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.jaad.2012.05.029","volume":"68","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido\u00a0C et al (2013) Identification and genotyping of human papillomavirus in a\u00a0Spanish cohort of penile squamous cell carcinomas: correlation with pathologic subtypes, p16(INK4a) expression, and prognosis. J\u00a0Am Acad Dermatol 68(1):73\u201382","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"1574_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1136\/jclinpath-2011-200429","volume":"65","author":"S Gunia","year":"2012","unstructured":"Gunia\u00a0S et\u00a0al (2012) Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis. J\u00a0Clin Pathol 65(3):232\u2013236","journal-title":"J Clin Pathol"},{"issue":"1","key":"1574_CR18","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-5347(05)64836-7","volume":"168","author":"A Lopes","year":"2002","unstructured":"Lopes\u00a0A et\u00a0al (2002) p53 as a\u00a0new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82\u00a0patients treated with amputation and bilateral lymphadenectomy. J\u00a0Urol 168(1):81\u201386","journal-title":"J Urol"},{"issue":"1","key":"1574_CR19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1464-410X.2007.06908.x","volume":"100","author":"Y Zhu","year":"2007","unstructured":"Zhu\u00a0Y et al (2007) The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase\u20119 in penile squamous cell carcinoma treated with surgery. BJU Int 100(1):204\u2013208","journal-title":"BJU Int"},{"issue":"6","key":"1574_CR20","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.juro.2013.06.015","volume":"190","author":"C Ferrandiz-Pulido","year":"2013","unstructured":"Ferrandiz-Pulido\u00a0C et al (2013) mTOR signaling pathway in penile squamous cell carcinoma: pmTOR and peIF4E over expression correlate with aggressive tumor behavior. J\u00a0Urol 190(6):2288\u20132295","journal-title":"J Urol"},{"issue":"6","key":"1574_CR21","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1007\/s00345-013-1024-4","volume":"31","author":"JY Liu","year":"2013","unstructured":"Liu\u00a0JY et\u00a0al (2013) The risk factors for the presence of pelvic lymph node metastasis in penile squamous cell carcinoma patients with inguinal lymph node dissection. World J Urol 31(6):1519\u20131524","journal-title":"World J Urol"},{"issue":"1","key":"1574_CR22","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0022-5347(05)65389-X","volume":"167","author":"AC Martins","year":"2002","unstructured":"Martins\u00a0AC et\u00a0al (2002) Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J\u00a0Urol 167(1):89\u201393","journal-title":"J Urol"},{"issue":"24","key":"1574_CR23","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1158\/0008-5472.CAN-15-1004","volume":"75","author":"AS McDaniel","year":"2015","unstructured":"McDaniel\u00a0AS et\u00a0al (2015) Genomic profiling of penile squamous cell carcinoma reveals new opportunities for targeted therapy. Cancer Res 75(24):5219\u20135227","journal-title":"Cancer Res"},{"issue":"6","key":"1574_CR24","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.clgc.2016.03.005","volume":"14","author":"A Necchi","year":"2016","unstructured":"Necchi\u00a0A et al (2016) Prognostic factors of adjuvant taxane, cisplatin, and 5\u2011Fluorouracil chemotherapy for patients with penile squamous cell carcinoma after regional lymphadenectomy. Clin Genitourin Cancer 14(6):518\u2013523","journal-title":"Clin Genitourin Cancer"},{"issue":"4","key":"1574_CR25","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.humpath.2011.06.013","volume":"43","author":"RM Rocha","year":"2012","unstructured":"Rocha\u00a0RM et\u00a0al (2012) A clinical, pathologic, and molecular study of p53 and murine double minute 2 in penile carcinogenesis and its relation to prognosis. Hum Pathol 43(4):481\u2013488","journal-title":"Hum Pathol"},{"issue":"3 Pt 1","key":"1574_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.juro.2016.09.088","volume":"197","author":"SR Ottenhof","year":"2017","unstructured":"Ottenhof\u00a0SR et\u00a0al (2017) Expression of programmed death ligand 1 in penile cancer is of prognostic value and associated with HPV status. J\u00a0Urol 197(3 Pt 1):690\u2013697","journal-title":"J Urol"},{"issue":"9","key":"1574_CR27","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1093\/annonc\/mdw216","volume":"27","author":"AM Udager","year":"2016","unstructured":"Udager\u00a0AM et al (2016) Frequent PD-L1 expression in primary and metastatic penile squamous cell carcinoma: potential opportunities for immunotherapeutic approaches. Ann Oncol 27(9):1706\u20131712","journal-title":"Ann Oncol"},{"issue":"6","key":"1574_CR34","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/his.13429","volume":"72","author":"AL Cubilla","year":"2018","unstructured":"Cubilla\u00a0AL, Velazquez\u00a0EF, Amin\u00a0MB, Epstein\u00a0J, Berney\u00a0DM, Corbishley\u00a0CM, ISUP Penile Tumor Panel (2018) The World Health Organisation 2016 classification of penile carcinomas: a\u00a0review and update from the International Society of Urological Pathology expert-driven recommendations. Histopathology 72(6):893\u2013904. https:\/\/doi.org\/10.1111\/his.13429","journal-title":"Histopathology"},{"issue":"10","key":"1574_CR35","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.urolonc.2017.10.010","volume":"36","author":"K Zargar-Shoshtari","year":"2018","unstructured":"Zargar-Shoshtari\u00a0K, Sharma\u00a0P, Spiess\u00a0PE (2018) Insight into novel biomarkers in penile cancer: redefining the present and future treatment paradigm? Urol Oncol 36(10):433\u2013439","journal-title":"Urol Oncol"},{"key":"1574_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-34516-6","volume-title":"Cancer grading manual","author":"I Damjanov","year":"2013","unstructured":"Damjanov\u00a0I, Fan\u00a0F (2013) Cancer grading manual, 1.\u00a0Aufl. Springer, Berlin Heidelberg","edition":"1"},{"key":"1574_CR37","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1001\/jama.1920.02620100016007","volume":"74","author":"AC Broders","year":"1920","unstructured":"Broders\u00a0AC (1920) Squamous cell epithelioma of the lip: a\u00a0study of five hundred thirty-seven cases. JAMA 74:656\u2013664","journal-title":"JAMA"},{"key":"1574_CR38","doi-asserted-by":"publisher","unstructured":"Histopathology 2018, 72, 893\u2013904. DOI: https:\/\/doi.org\/10.1111\/his.13429","DOI":"10.1111\/his.13429"},{"key":"1574_CR39","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41379-019-0249-1","volume":"32","author":"L Nicolas","year":"2019","unstructured":"Nicolas\u00a0L (2019) Update on premalignant cervical squamous lesions. Mod Pathol 32:1189\u20131196","journal-title":"Mod Pathol"},{"issue":"4","key":"1574_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun\u00a0A, de Reyni\u00e8s\u00a0A, Allory\u00a0Y, Sj\u00f6dahl\u00a0G, Robertson\u00a0AG, Seiler\u00a0R, Hoadley\u00a0KA et al (2020) Bladder cancer molecular taxonomy group. A consensus molecular classification of muscle-invasive bladder cancer. Eur Urol 77(4):420\u2013433","journal-title":"Eur Urol"},{"key":"1574_CR41","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1100\/tsw.2011.24","volume":"11","author":"MF Calmon","year":"2011","unstructured":"Calmon\u00a0MF, Tasso Mota\u00a0M, Vassallo\u00a0J et\u00a0al (2011) Penile carcinoma: risk factors and molecular alterations. ScientificWorldJournal 11:269\u2013282","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"1574_CR42","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00428-010-1007-4","volume":"458","author":"M Poetsch","year":"2011","unstructured":"Poetsch\u00a0M, Hemmerich\u00a0M, Kakies\u00a0C, Kleist\u00a0B, Wolf\u00a0E, vom Dorp\u00a0F, Hakenberg\u00a0OW, Protzel\u00a0C (2011) Alterations in the tumor suppressor gene p16(INK4A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458(2):221\u2013229","journal-title":"Virchows Arch"},{"issue":"4","key":"1574_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00428-008-0590-0","volume":"452","author":"C Protzel","year":"2008","unstructured":"Protzel\u00a0C, Kakies\u00a0C, Kleist\u00a0B, Poetsch\u00a0M, Giebel\u00a0J (2008) Down-regulation of the metastasis suppressor protein KAI1\/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma. Virchows Arch 452(4):369\u2013375","journal-title":"Virchows Arch"},{"key":"1574_CR44","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1007\/s00120-019-0973-7","volume":"58","author":"C Protzel","year":"2019","unstructured":"Protzel\u00a0C, Hakenberg\u00a0OW (2019) Molekulares Tumorboard Peniskarzinom \u2013 eine Herausforderung. Urologe 58:774\u2013780","journal-title":"Urologe"},{"issue":"6","key":"1574_CR45","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/his.12338","volume":"64","author":"A Chaux","year":"2014","unstructured":"Chaux\u00a0A, Munari\u00a0E, Cubilla\u00a0AL, Hicks\u00a0J, Lecksell\u00a0K, Burnett\u00a0AL, Netto\u00a0GJ (2014) Immunohistochemical expression of the mammalian target of rapamycin pathway in penile squamous cell carcinomas: a\u00a0tissue microarray study of 112\u00a0cases. Histopathology 64(6):863\u2013871","journal-title":"Histopathology"},{"issue":"1","key":"1574_CR46","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1016\/j.clgc.2018.09.012","volume":"17","author":"M Azizi","year":"2018","unstructured":"Azizi\u00a0M, Tang\u00a0DH, Verduzco\u00a0D, Peyton\u00a0CC, Chipollini\u00a0J, Yuan\u00a0Z, Schaible\u00a0BJ, Zhou\u00a0JM, Johnstone\u00a0PA, Giuliano\u00a0A, Dhillon\u00a0J, Spiess\u00a0PE (2018) Impact of PI3K-AKT-mTOR signaling pathway up-regulation on prognosis of penile squamous-cell carcinoma: results from a\u00a0tissue microarray study and review of the literature. Clin Genitourin Cancer 17(1):e80\u2013e91","journal-title":"Clin Genitourin Cancer"},{"key":"1574_CR47","first-page":"47","volume":"20","author":"DS Zekan","year":"2021","unstructured":"Zekan\u00a0DS, Dahman\u00a0A, Hajiran\u00a0AJ, Luchey\u00a0AM, Chahoud\u00a0J, Spiess\u00a0PE (2021) Prognostic predictors of lymph node metastasis in penile cancer: a\u00a0systematic review. Int Braz J Urol 20:47","journal-title":"Int Braz J Urol"},{"issue":"2","key":"1574_CR48","first-page":"1091","volume":"41","author":"X Hu","year":"2019","unstructured":"Hu\u00a0X, Chen\u00a0M, Li\u00a0Y, Wang\u00a0Y, Wen\u00a0S, Jun\u00a0F (2019) Overexpression of ID1 promotes tumor progression in penile squamous cell carcinoma. Oncol Rep 41(2):1091\u20131100","journal-title":"Oncol Rep"},{"issue":"3","key":"1574_CR49","doi-asserted-by":"publisher","first-page":"854","DOI":"10.3390\/ijms21030854","volume":"21","author":"C Idel","year":"2020","unstructured":"Idel\u00a0C, Ribbat-Idel\u00a0J, Kuppler\u00a0P, Krupar\u00a0R, Offermann\u00a0A, Vogel\u00a0W, Rades\u00a0D, Kirfel\u00a0J, Wollenberg\u00a0B, Perner\u00a0S (2020) EVI1 as a\u00a0Marker for Lymph Node Metastasis in HNSCC. Int J Mol Sci 21(3):854","journal-title":"Int J Mol Sci"},{"issue":"5","key":"1574_CR28","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/RLU.0b013e318238f6ea","volume":"37","author":"R Sadeghi","year":"2012","unstructured":"Sadeghi\u00a0R et al (2012) Accuracy of 18F-FDG PET\/CT for diagnosing inguinal lymph node involvement in penile squamous cell carcinoma: systematic review and meta-analysis of the literature. Clin Nucl Med 37(5):436\u2013441","journal-title":"Clin Nucl Med"},{"issue":"5","key":"1574_CR29","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/j.1464-410X.2009.08450.x","volume":"104","author":"JA Leijte","year":"2009","unstructured":"Leijte\u00a0JA et al (2009) Prospective evaluation of hybrid 18F-fluorodeoxyglucose positron emission tomography\/computed tomography in staging clinically node-negative patients with penile carcinoma. BJU Int 104(5):640\u2013644","journal-title":"BJU Int"},{"issue":"1","key":"1574_CR30","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/MOU.0b013e3282f151fd","volume":"18","author":"UG Mueller-Lisse","year":"2008","unstructured":"Mueller-Lisse\u00a0UG, Scher\u00a0B, Scherr\u00a0MK, Seitz\u00a0M (2008) Functional imaging in penile cancer: PET\/computed tomography, MRI, and sentinel lymph node biopsy. Curr Opin Urol 18(1):105\u2013110","journal-title":"Curr Opin Urol"},{"issue":"9","key":"1574_CR31","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1111\/j.1464-410X.2008.07744.x","volume":"102","author":"CM Naumann","year":"2008","unstructured":"Naumann\u00a0CM et al (2008) Lymph-node metastases in intermediate-risk squamous cell carcinoma of the penis. BJU Int 102(9):1102\u20131106","journal-title":"BJU Int"},{"issue":"11","key":"1574_CR32","doi-asserted-by":"publisher","first-page":"1424, 1426","DOI":"10.1007\/s00120-006-1160-1","volume":"45","author":"CM Naumann","year":"2006","unstructured":"Naumann\u00a0CM et\u00a0al (2006) The influence of the T stage on the risk of metastasis of penis cancer: T1 vs. T2. Urologe 45(11):1424, 1426\u20131424, 1430","journal-title":"Urologe"},{"issue":"6","key":"1574_CR33","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/jso.20980","volume":"97","author":"AA Ornellas","year":"2008","unstructured":"Ornellas\u00a0AA et al (2008) Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J\u00a0Surg Oncol 97(6):487\u2013495","journal-title":"J Surg Oncol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00120-021-01574-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-021-01574-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T13:04:25Z","timestamp":1626181465000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00120-021-01574-w"}},"subtitle":["Entscheidungshilfen f\u00fcr den klinischen Alltag"],"short-title":[],"issued":{"date-parts":[[2021,6,28]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1007\/s00120-021-01574-w","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,28]]},"assertion":[{"value":"26 May 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Kakies, D.\u00a0Louise Dr\u00e4ger, P.\u00a0Spiess, O.\u00a0W.\u00a0Hakenberg und C.\u00a0Protzel geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}